Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision Expands Facilities with Plans for Adding Next-Gen Sequencing and Other New Services

NEW YORK (GenomeWeb News) – Belgian applied genetics and genomics services company DNAVision announced today that it has doubled its laboratories and office space in Charleroi-Gosselies, Belgium, adding five new laboratory areas dedicated to cell culture and nucleic acid extraction.
 
The move is aimed at augmenting the company’s RNA- and DNA-based analytical techniques, expanding its biopharmaceutical services portfolio, and providing new GMP certified assays.
 
DNAVision said that its DNAVision AgriFood subsidiary, a spin-off of the University of Liège, will move to a new facility at the end of this month. Along with biosafety level 3 laboratory services, DNAVision said it will also provide a range of new services including next-generation sequencing, though it did not provide details on the sequencing platform it plans to use.
 
In a statement today, DNAVision CEO Jean-Pol Detiffe said that the firm’s revenues increased more than 50 percent in 2008.
 
He also noted that the company plans to launch consumer genetic services this year.
 
DNAVision, a spin-out of the University of Brussels, has experience providing nucleic acid extraction and purification services. Most of these extraction services are accredited by the Belgian accreditation body BELAC.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.